[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - June 2005

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 77-214 ZOLPIDEM TARTRATE TABLETS 5 MG AND 10 MG   ROXANE LABORATORIES, INC. 6/6/2005 
2 77-464 LAMIVUDINE TABLETS 150 MG AND 300 MG   AUROBINDO PHARMA LIMITED 6/15/2005 
3 77-444 TERBINAFINE HYDROCHLORIDE TABLETS 250 MG (BASE)   RANBAXY LABORATORIES, LTD. 6/16/2005 
4 76-506 ONDANSETRON ORALLY DISINTEGRATING TABLETS 4 MG, AND 8 MG   KALI LABORATORIES, INC. 6/17/2005 
5 77-304 CAFFEINE CITRATE ORAL SOLUTION 10 MG (BASE)/ML   PHARMAFORCE, INC. 6/20/2005 
6 77-233 CAFFEINE CITRATE INJECTION 20 MG (BASE)/ML   PHARMAFORCE, INC. 6/20/2005 
7 77-521 NEVIRAPINE TABLETS 200 MG   AUROBINDO PHARMA LIMITED 6/20/2005 
8 77-429 NEVIRAPINE TABLETS 200 MG   RANBAXY LABORATORIES LIMITED 6/20/2005 
9 77-073 AMLODIPINE BESYLATE TABLETS 2.5 MG (BASE), 5 MG (BASE), AND 10 MG (BASE)   WATSON LABORATORIES, INC. 6/22/2005 
10 77-673 EFAVIRENZ TABLETS 600 MG   AUROBINDO PHARMA LIMITED 6/24/2005 
11 76-802 GLIMEPIRIDE TABLETS 1 MG, 2 MG, AND 4 MG   TEVA PHARMACEUTICALS USA 6/27/2005 
12 77-013 PRAVASTATIN SODIUM TABLETS 10 MG, 20 MG, 40 MG, AND 80 MG   GENPHARM INC. 6/27/2005 
13 77-223 TERBINAFINE HYDROCHLORIDE TABLETS 250 MG (BASE)   ROXANE LABORATORIES, INC. 6/27/2005 

Back to Top     Back to Approvals

Date created: July 7, 2005

horizonal rule